QMSR Inspection Readiness Self-Assessment

FDA inspections under the Quality Management System Regulation (QMSR) represent a fundamental shift in how medical device manufacturers are evaluated. Inspections are no longer structured as checklist-based reviews of isolated subsystems. Instead, they are risk-driven, data-informed investigations that assess how a quality system performs across the total product lifecycle.

This self-assessment is designed to help organizations evaluate their readiness for that inspection model. It focuses on the areas most likely to be examined under FDA’s Compliance Program, including system integration, risk management, CAPA effectiveness, design controls, and postmarket feedback.

Each question reflects not just regulatory requirements, but how FDA investigators are now interpreting and applying those requirements in practice.

Use this tool to identify gaps, pressure-test your system, and better understand how your organization may perform under a QMSR inspection.

The most common misconception about QMSR is that it is a documentation exercise. It is not. FDA is no longer evaluating whether procedures exist. It is evaluating whether your system functions consistently, coherently, and in a way that manages risk across the lifecycle of your products.

Organizations that approach QMSR as a mapping exercise or procedural update will struggle. Those that focus on system integration, data flow, and risk-based decision-making will be far better positioned.

Next Steps

If your assessment indicates moderate readiness or elevated risk, the next step is not necessarily more documentation, it is system alignment. We support organizations through QMSR gap assessments, inspection readiness programs, mock FDA inspections, risk integration, and system alignment.

If you would like to discuss your results or explore next steps, contact us to discuss a structured QMSR readiness strategy.